MedPath

Artificial Intelligence for Automated Diagnosis of Breast Cancer

Recruiting
Conditions
Breast Cancer Diagnosis
Registration Number
NCT05858762
Lead Sponsor
Regina Elena Cancer Institute
Brief Summary

Mammography is a two-dimensional imaging technique which involves the tissues overlapping under the projective image; dense glandular tissue above or below the lesion can reduce the visibility of the lesion.

The trouble could be the interpretation of the image obtained which may lead to the inability to visualize a fist stage cancer and the probability that to a healthy person will be diagnosed a pathology that is not present (false positive). The introduction of an almost three-dimensional technique imaging called breast digital tomosynthesis (DBT) can overcome most limitations. In the last 5 years image analysis methods based on Artificial Intelligence (, AI) have also been massively introduced in breast cancer detection. The study is a prospective observational study based on Artificial intelligence whose the mail goal is to develop a method to identify a lesion.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Patients who refer to the Regina Elena for diagnostic mammography tests
  • Informed consent
Exclusion Criteria
  • presence of prostheses, artifacts, outcomes of a study in the breast intervention under the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Artificial Intelligence system to detect a lesion12 months

Lesion detction is based on breast density, case type, BIRADS assessment categories, mammographic appearance, size and pathological profile of malignant lesions

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

"Regina Elena" National Cancer Institute

🇮🇹

Rome, Italy

Università degli Studi di Napoli Federico II

🇮🇹

Napoli, Italy

© Copyright 2025. All Rights Reserved by MedPath